Atrial natriuretic peptide and leptin interactions in healthy men
Open Access
- 30 June 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1195677
Abstract
Introduction: Atrial natriuretic peptide (ANP), a hormone secreted from the heart, controls cardiovascular and renal functions including arterial blood pressure and natriuresis. ANP also exerts metabolic effects in adipose tissue, liver and skeletal muscle, and interacts with the secretion of adipokines. We tested the hypothesis that ANP lowers concentrations of the anorexigenic adipokine leptin in healthy humans in vivo.Methods: Human ANP or matching placebo was infused intravenously (iv) into healthy men in a controlled clinical trial.Results: Within 135 minutes of iv ANP infusion, we observed an acute decrease in plasma leptin levels compared to controls. Free fatty acids markedly increased with ANP infusion in vivo, indicating activated lipolysis. In human SGBS adipocytes, ANP suppressed leptin release.Discussion: The study shows that the cardiac hormone ANP reduces the levels of the anorexigenic adipokine leptin in healthy humans, providing further support for ANP as a cardiomyokine in a heart - adipose tissue axis. (registered in the German Clinical Trials Register and the WHO International Clinical Trials Registry Platform was granted under DRKS00024559)Keywords
This publication has 24 references indexed in Scilit:
- Metabolic actions of natriuretic peptides and therapeutic potential in the metabolic syndromePharmacology & Therapeutics, 2014
- Natriuretic peptides enhance the oxidative capacity of human skeletal muscleJournal of Clinical Investigation, 2012
- Atrial Natriuretic Peptide and Adiponectin Interactions in ManPLOS ONE, 2012
- Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytesJournal of Clinical Investigation, 2012
- Phosphodiesterase type 5 (PDE5) in the adipocyte: a novel player in fat metabolism?Trends in Endocrinology & Metabolism, 2011
- Atrial Natriuretic Peptide Induces Postprandial Lipid Oxidation in HumansDiabetes, 2008
- Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissueDiabetologia, 2007
- β-Adrenergic and Atrial Natriuretic Peptide Interactions on Human Cardiovascular and Metabolic RegulationThe Journal of Clinical Endocrinology & Metabolism, 2006
- Lipid Mobilization with Physiological Atrial Natriuretic Peptide Concentrations in HumansThe Journal of Clinical Endocrinology & Metabolism, 2005
- Characterization of a human preadipocyte cell strain with high capacity for adipose differentiationInternational Journal of Obesity, 2001